Unlikely to cause harm — often a labeling or packaging issue.
Labeling: Label Error on Declared Strength: Incorrect strength on side display panel of label
| Brand name | LISINOPRIL |
| Generic name | LISINOPRIL |
| Active ingredient(s) | LISINOPRIL |
| Distributed by / for | Aurobindo Pharma USA Inc. 2400 Route 130 North, Dayton, NJ 08810 |
| NDC | 65862-041-01 |
| Full product label | Lisinopril Tablets, USP, 30 mg, Rx only, 100 tablets, NDC 65862-041-01 Manufactured for: Aurobindo Pharma USA Inc. 2400 Route 130 North, Dayton, NJ 08810 Manufactured by: Aurobindo Pharma Limited Hyderabad- 500 072 India |
| Recalling firm | Aurobindo Pharma USA Inc |
| Distribution | Nationwide |
| Quantity | 1776 bottles |
| Recall initiated | 2013-04-09 |
| Report date | 2013-06-05 |
| Recall completed | 2014-01-23 |
| Recall number | D-498-2013 |
| Classification | Class III |
| FDA status | Terminated |
| Origin on file | Plainsboro NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗